Chang-Douglass, Stacey <br/><br/>
Cannabis-based medicinal products: summary of NICE guidance.  [electronic resource] 

 -  BMJ (Clinical research ed.)  Apr 2020 
 - m1108 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1756-1833 
<br/><br/><label>Standard No.: </label>10.1136/bmj.m1108  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiemetics--therapeutic use<br/>Antineoplastic Agents--adverse effects<br/>Cannabidiol--therapeutic use<br/>Cannabinoid Receptor Agonists--therapeutic use<br/>Chronic Pain--drug therapy<br/>Decision Making, Shared<br/>Dronabinol--analogs & derivatives<br/>Drug Resistant Epilepsy--drug therapy<br/>Drug and Narcotic Control<br/>Epilepsies, Myoclonic--drug therapy<br/>Humans<br/>Lennox Gastaut Syndrome--drug therapy<br/>Medical Marijuana--therapeutic use<br/>Multiple Sclerosis--complications<br/>Muscle Spasticity--drug therapy<br/>Nausea--chemically induced<br/>Needs Assessment<br/>Physicians, Primary Care<br/>Practice Guidelines as Topic<br/>Specialization<br/>United Kingdom<br/>Vomiting--chemically induced